NMR in pharmaceutical discovery and development

Raymond S Norton^{1

2}, Wolfgang Jahnke³

Affiliations

¹ Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia. ray.norton@monash.edu.
² ARC Centre for Fragment-Based Design, Monash University, Parkville, VIC, 3052, Australia. ray.norton@monash.edu.
³ Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Virchow-16.3.249, 4002, Basel, Switzerland. wolfgang.jahnke@novartis.com.

Editorial

Raymond S Norton et al. J Biomol NMR. 2020 Nov.

. 2020 Nov;74(10-11):473-476.

doi: 10.1007/s10858-020-00345-7. Epub 2020 Sep 4.

Raymond S Norton^{1

2}, Wolfgang Jahnke³

¹ Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia. ray.norton@monash.edu.
² ARC Centre for Fragment-Based Design, Monash University, Parkville, VIC, 3052, Australia. ray.norton@monash.edu.
³ Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Virchow-16.3.249, 4002, Basel, Switzerland. wolfgang.jahnke@novartis.com.

Erratum in

Correction to: NMR in pharmaceutical discovery and development.
Norton RS, Jahnke W. Norton RS, et al. J Biomol NMR. 2020 Nov;74(10-11):477. doi: 10.1007/s10858-020-00351-9. J Biomol NMR. 2020. PMID: 33185771

No abstract available